{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:14:31Z","timestamp":1781712871686,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24am0521010 and JP24ama121008"],"award-info":[{"award-number":["JP24am0521010 and JP24ama121008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Program of the National Institutes of Health, National Cancer Institute","award":["ZIA BC 011513"],"award-info":[{"award-number":["ZIA BC 011513"]}]},{"DOI":"10.13039\/100009451","name":"Osteopathic Heritage Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","award":["PC78-24NIH"],"award-info":[{"award-number":["PC78-24NIH"]}],"id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15CA271044-01 and 1R41CA268160-01A1"],"award-info":[{"award-number":["1R15CA271044-01 and 1R41CA268160-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06265-z","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T01:41:20Z","timestamp":1752889280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Maackia amurensis seed lectin (MASL) on OSCC cell morphology, PDPN expression, growth, and motility in a phase 1 clinical trial"],"prefix":"10.1007","volume":"151","author":[{"given":"Ariel C.","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayla J.","family":"Holdcraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Helmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn J.","family":"Brace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Suster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Shienbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Kalyoussef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghayoour","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Capitle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soly","family":"Baredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabie M.","family":"Shanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika K.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisataka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Fatahzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"6265_CR1","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/bit.28452","volume":"120","author":"G Baskar","year":"2023","unstructured":"Baskar G et al (2023) Recent and advanced therapy for oral cancer. Biotechnol Bioeng 120:3105\u20133115. https:\/\/doi.org\/10.1002\/bit.28452","journal-title":"Biotechnol Bioeng"},{"key":"6265_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA. Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"Cancer J Clin"},{"key":"6265_CR3","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-14-0728","volume":"74","author":"C Bull","year":"2014","unstructured":"Bull C, Stoel MA, den Brok MH, Adema GJ (2014) Sialic acids sweeten a tumor\u2019s life. Cancer Res 74:3199\u20133204. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0728","journal-title":"Cancer Res"},{"key":"6265_CR4","doi-asserted-by":"publisher","first-page":"40637","DOI":"10.3390\/biom10040637","volume":"10","author":"P Carpintero-Fernandez","year":"2020","unstructured":"Carpintero-Fernandez P, Varela-Eirin M, Lacetera A, Gago-Fuentes R, Fonseca E, Martin-Santamaria S, Mayan MD (2020) New therapeutic strategies for osteoarthritis by targeting Sialic acid receptors. Biomolecules 10:40637. https:\/\/doi.org\/10.3390\/biom10040637","journal-title":"Biomolecules"},{"key":"6265_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","volume":"558","author":"N Chihara","year":"2018","unstructured":"Chihara N et al (2018) Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature 558:454\u2013459. https:\/\/doi.org\/10.1038\/s41586-018-0206-z","journal-title":"Nature"},{"key":"6265_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.oraloncology.2018.10.013","volume":"87","author":"AK D\u2019Cruz","year":"2018","unstructured":"D\u2019Cruz AK, Vaish R, Dhar H (2018) Oral cancers: current status. Oral Oncol 87:64\u201369. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.10.013","journal-title":"Oral Oncol"},{"key":"6265_CR7","doi-asserted-by":"publisher","first-page":"2019922","DOI":"10.1080\/2162402X.2021.2019922","volume":"11","author":"A Furusawa","year":"2022","unstructured":"Furusawa A et al (2022) CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented. Melanoma Model Oncoimmunology 11:2019922. https:\/\/doi.org\/10.1080\/2162402X.2021.2019922","journal-title":"Melanoma Model Oncoimmunology"},{"key":"6265_CR8","doi-asserted-by":"publisher","first-page":"1487306","DOI":"10.3389\/fonc.2024.1487306","volume":"14","author":"IF Habeeb","year":"2024","unstructured":"Habeeb IF, Alao TE, Delgado D, Buffone A Jr. (2024) When a negative (charge) is not a positive: sialylation and its role in cancer mechanics and progression. Front Oncol 14:1487306. https:\/\/doi.org\/10.3389\/fonc.2024.1487306","journal-title":"Front Oncol"},{"key":"6265_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00432-020-03456-8","volume":"147","author":"KL Hamilton","year":"2021","unstructured":"Hamilton KL et al (2021) Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways. J Cancer Res Clin Oncol 147:445\u2013457. https:\/\/doi.org\/10.1007\/s00432-020-03456-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"6265_CR9","doi-asserted-by":"publisher","first-page":"101341","DOI":"10.1016\/j.bbrep.2022.101341","volume":"32","author":"KL Hamilton","year":"2022","unstructured":"Hamilton KL, Greenspan AA, Shienbaum AJ, Fischer BD, Bottaro A, Goldberg GS (2022) Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFalpha induced rheumatoid arthritis. Biochem Biophys Rep 32:101341. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101341","journal-title":"Biochem Biophys Rep"},{"key":"6265_CR11","volume-title":"Ancient and traditional foods, plants, herbs and spices used in Cancer","author":"TJ Hellmig","year":"2023","unstructured":"Hellmig TJ et al (2023) Amur maackia (Maackia amurensis) seed lectin history and potential effect on cancer progression, inflammation, and viral infection. In: Rajendram R, Preedy V, Patel V (eds) Ancient and traditional foods, plants, herbs and spices used in Cancer. Taylor and Francis, Oxfordshire"},{"key":"6265_CR12","doi-asserted-by":"publisher","first-page":"807600","DOI":"10.3389\/fimmu.2021.807600","volume":"12","author":"BO Hwang","year":"2021","unstructured":"Hwang BO et al (2021) Platelet CLEC2-podoplanin axis as a promising target for oral cancer. Treat Front Immunol 12:807600. https:\/\/doi.org\/10.3389\/fimmu.2021.807600","journal-title":"Treat Front Immunol"},{"key":"6265_CR13","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3390\/cells9112529","volume":"9","author":"S Kamoto","year":"2020","unstructured":"Kamoto S et al (2020) Phase i\/ii clinical trial of the anti-podoplanin monoclonal antibody therapy in dogs with malignant melanoma. Cells 9:2529. https:\/\/doi.org\/10.3390\/cells9112529","journal-title":"Cells"},{"key":"6265_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/1535-7163.MCT-22-0313","volume":"22","author":"T Kato","year":"2023","unstructured":"Kato T et al (2023) Near-infrared photoimmunotherapy targeting podoplanin-expressing cancer cells and cancer-associated fibroblasts. Mol Cancer Ther 22:75\u201388. https:\/\/doi.org\/10.1158\/1535-7163.MCT-22-0313","journal-title":"Mol Cancer Ther"},{"key":"6265_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/intimm\/dxaa037","volume":"33","author":"H Kobayashi","year":"2021","unstructured":"Kobayashi H, Furusawa A, Rosenberg A, Choyke PL (2021) Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity. Int Immunol 33:7\u201315. https:\/\/doi.org\/10.1093\/intimm\/dxaa037","journal-title":"Int Immunol"},{"key":"6265_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/cas.13580","volume":"109","author":"H Krishnan","year":"2018","unstructured":"Krishnan H et al (2018) Podoplanin: an emerging cancer biomarker and therapeutic target. Cancer Sci 109:1292\u20131299. https:\/\/doi.org\/10.1111\/cas.13580","journal-title":"Cancer Sci"},{"key":"6265_CR17","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.3390\/cancers15215117","volume":"15","author":"NL Miyazaki","year":"2023","unstructured":"Miyazaki NL, Furusawa A, Choyke PL, Kobayashi H (2023) Review of RM-1929 Near-Infrared photoimmunotherapy clinical efficacy for unresectable and\/or recurrent head and neck squamous cell carcinoma cancers. (Basel) 15:5117. https:\/\/doi.org\/10.3390\/cancers15215117","journal-title":"(Basel)"},{"key":"6265_CR18","doi-asserted-by":"publisher","first-page":"e389810","DOI":"10.1200\/EDBK_389810","volume":"43","author":"I Mohamad","year":"2023","unstructured":"Mohamad I, Glaun MDE, Prabhash K, Busheri A, Lai SY, Noronha V, Hosni A (2023) Current treatment strategies and risk stratification for oral carcinoma. Am Soc Clin Oncol Educ Book 43:e389810. https:\/\/doi.org\/10.1200\/EDBK_389810","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"6265_CR19","doi-asserted-by":"publisher","first-page":"32655","DOI":"10.3390\/ijms24032655","volume":"24","author":"TM Mohiuddin","year":"2023","unstructured":"Mohiuddin TM, Zhang C, Sheng W, Al-Rawe M, Zeppernick F, Meinhold-Heerlein I, Hussain AF (2023) Near infrared photoimmunotherapy: a review of recent progress and their target molecules for cancer therapy. Int J Mol Sci 24:32655. https:\/\/doi.org\/10.3390\/ijms24032655","journal-title":"Int J Mol Sci"},{"key":"6265_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/odi.14378","volume":"30","author":"L Monteiro","year":"2024","unstructured":"Monteiro L, Mariano LC, Warnakulasuriya S (2024) Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: a systematic review and meta-analysis. Oral Dis 30:207\u2013215. https:\/\/doi.org\/10.1111\/odi.14378","journal-title":"Oral Dis"},{"key":"6265_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/intimm\/dxad042","volume":"36","author":"K Nakajima","year":"2024","unstructured":"Nakajima K, Ogawa M (2024) Near-infrared photoimmunotherapy and anti-cancer immunity. Int Immunol 36:57\u201364. https:\/\/doi.org\/10.1093\/intimm\/dxad042","journal-title":"Int Immunol"},{"key":"6265_CR22","doi-asserted-by":"publisher","first-page":"108466","DOI":"10.1016\/j.jbc.2025.108466","volume":"301","author":"AR Nayak","year":"2025","unstructured":"Nayak AR et al (2025) Maackia amurensis seed lectin (MASL) structure and sequence comparison with other Maackia amurensis lectins. J Biolog Chem 301:108466. https:\/\/doi.org\/10.1016\/j.jbc.2025.108466","journal-title":"J Biolog Chem"},{"key":"6265_CR23","doi-asserted-by":"publisher","unstructured":"Nicoletto RE et al (2024) Effects of cadherin mediated contact normalization on oncogenic Src kinase mediated gene expression and protein phosphorylation Scientific reports 14:23942 https:\/\/doi.org\/10.1038\/s41598-024-75449-3","DOI":"10.1038\/s41598-024-75449-3"},{"key":"6265_CR24","doi-asserted-by":"publisher","first-page":"91321","DOI":"10.1172\/jci.insight.92321","volume":"2","author":"AN Nylander","year":"2017","unstructured":"Nylander AN et al (2017) Podoplanin is a negative regulator of Th17 inflammation. JCI Insight 2:91321. https:\/\/doi.org\/10.1172\/jci.insight.92321","journal-title":"JCI Insight"},{"key":"6265_CR25","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.18632\/oncotarget.3515","volume":"6","author":"JA Ochoa-Alvarez","year":"2015","unstructured":"Ochoa-Alvarez JA et al (2015) Antibody and lectin target Podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms. Oncotarget 6:9045\u20139060","journal-title":"Oncotarget"},{"key":"6265_CR26","doi-asserted-by":"publisher","first-page":"CD006386","DOI":"10.1002\/14651858.CD006386.pub4","volume":"12","author":"A Parmar","year":"2021","unstructured":"Parmar A et al (2021) Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev 12:CD006386. https:\/\/doi.org\/10.1002\/14651858.CD006386.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"6265_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1172\/JCI74685","volume":"125","author":"A Peters","year":"2015","unstructured":"Peters A, Burkett PR, Sobel RA, Buckley CD, Watson SP, Bettelli E, Kuchroo VK (2015) Podoplanin negatively regulates CD4\u2009+\u2009effector T cell responses. J Clin Investig 125:129\u2013140. https:\/\/doi.org\/10.1172\/JCI74685","journal-title":"J Clin Investig"},{"key":"6265_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/ijms20030707","volume":"20","author":"M Quintanilla","year":"2019","unstructured":"Quintanilla M, Montero-Montero L, Renart J, Martin-Villar E (2019) Podoplanin in inflammation and cancer. Int J Mol Sci 20:707. https:\/\/doi.org\/10.3390\/ijms20030707","journal-title":"Int J Mol Sci"},{"key":"6265_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.oraloncology.2018.01.011","volume":"78","author":"EP Retzbach","year":"2018","unstructured":"Retzbach EP et al (2018) Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target. Oral Oncol 78:126\u2013136. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.01.011","journal-title":"Oral Oncol"},{"key":"6265_CR30","doi-asserted-by":"publisher","first-page":"105841","DOI":"10.1016\/j.archoralbio.2023.105841","volume":"157","author":"E Sayuddin","year":"2024","unstructured":"Sayuddin E, Taher M, Arzmi MH, Burhanudin NA, Rostam MA (2024) The role of Podoplanin inhibitors in controlling oral cancer progression. Arch Oral Biol 157:105841. https:\/\/doi.org\/10.1016\/j.archoralbio.2023.105841","journal-title":"Arch Oral Biol"},{"key":"6265_CR31","doi-asserted-by":"publisher","first-page":"112594","DOI":"10.1016\/j.yexcr.2021.112594","volume":"403","author":"SA Sheehan","year":"2021","unstructured":"Sheehan SA et al (2021) Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression. Exp Cell Res 403:112594. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112594","journal-title":"Exp Cell Res"},{"key":"6265_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-021-00817-9","volume":"20","author":"SA Sheehan","year":"2022","unstructured":"Sheehan SA, Retzbach EP, Shen Y, Krishnan H, Goldberg GS (2022) Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells. Cell Commun Signal 20:19. https:\/\/doi.org\/10.1186\/s12964-021-00817-9","journal-title":"Cell Commun Signal"},{"key":"6265_CR33","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1292\/jvms.23-0062","volume":"85","author":"M Shinada","year":"2023","unstructured":"Shinada M et al (2023) Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma. J Vet Med Sci 85:1068\u20131073. https:\/\/doi.org\/10.1292\/jvms.23-0062","journal-title":"J Vet Med Sci"},{"key":"6265_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/BD-230047","volume":"43","author":"K Singh","year":"2024","unstructured":"Singh K, Agrawal L, Gupta R, Singh D, Kathpalia M, Kaur N (2024) Lectins as a promising therapeutic agent for breast cancer: A review. Breast Dis 43:193\u2013211. https:\/\/doi.org\/10.3233\/BD-230047","journal-title":"Breast Dis"},{"key":"6265_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/cells11030575","volume":"11","author":"H Suzuki","year":"2022","unstructured":"Suzuki H, Kaneko MK, Kato Y (2022) Roles of Podoplanin in malignant progression of tumor. Cells 11:575. https:\/\/doi.org\/10.3390\/cells11030575","journal-title":"Cells"},{"key":"6265_CR36","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1158\/1078-0432.CCR-21-4509","volume":"28","author":"A Takemoto","year":"2022","unstructured":"Takemoto A et al (2022) Targeting Podoplanin for the treatment of osteosarcoma clinical cancer research: an official. J Am Assoc Cancer Res 28:2633\u20132645. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-4509","journal-title":"J Am Assoc Cancer Res"},{"key":"6265_CR37","doi-asserted-by":"publisher","first-page":"149881","DOI":"10.1016\/j.bbrc.2024.149881","volume":"710","author":"AC Yin","year":"2024","unstructured":"Yin AC et al (2024) Maackia amurensis seed lectin (MASL) and soluble human Podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability. Biochem Biophys Res Commun 710:149881. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149881","journal-title":"Biochem Biophys Res Commun"},{"key":"6265_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/cas.16046","volume":"115","author":"H Yoneda","year":"2024","unstructured":"Yoneda H et al (2024) Antipodoplanin antibody enhances the antitumor effects of CTLA-4 Blockade against malignant mesothelioma by natural killer cells. Cancer Sci 115:357\u2013368. https:\/\/doi.org\/10.1111\/cas.16046","journal-title":"Cancer Sci"},{"key":"6265_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41420-024-02180-3","volume":"10","author":"W Zhu","year":"2024","unstructured":"Zhu W, Zhou Y, Guo L, Feng S (2024) Biological function of Sialic acid and sialylation in human health and disease. Cell Death Discov 10:415. https:\/\/doi.org\/10.1038\/s41420-024-02180-3","journal-title":"Cell Death Discov"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06265-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:44:57Z","timestamp":1757256297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06265-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["6265"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06265-z","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare the following relationships which may be considered as potential competing interests: GSG has intellectual property and ownership in Sentrimed Inc. ACY and CJH have ownership and received financial support from Sentrimed Inc. which is developing agents including MASL that target podoplanin to treat diseases including cancer and arthritis. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"218"}}